Evidence map›Paper›PMID 26428623›Full record

ArticleBMC microbiology2015

Probiotic and anti-inflammatory attributes of an isolate Lactobacillus helveticus NS8 from Mongolian fermented koumiss.

Jingjing Rong, Houfeng Zheng, Ming Liu, Xu Hu, Tao Wang, Xingwei Zhang, Feng Jin, Li Wang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03664596 (Evaluation Of The Therapeutic And Dietary Properties Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis), which is not on this map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
10.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03664596 nacompletednot on this mapstarted 2018, after this paper: background citation

Evaluation Of The Therapeutic And Dietary Properties Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

TypeinterventionalSponsorMedical Centre Hospital of the President's Affairs Administration, Republic of KazakhstanRan2018 to 2020Enrolled80ConditionsNon-alcoholic SteatohepatitisArmsSublimated mare's milk, Ursodeoxycholic Acid
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Metagenomic Analysis Reveals the Anti-Inflammatory Properties of Mare Milk.International journal of molecular sciences · 2025
    Article
  6. Article
  7. Modulation of Macrophages TLR4-Mediated Transcriptional Response byInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Supplementation withFrontiers in immunology · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jingjing RongThe Affiliated Hospital, School of Medicine, Hangzhou Normal University, Hangzhou, China. jjrong@hznu.edu.cn.
Houfeng ZhengThe Affiliated Hospital, School of Medicine, Hangzhou Normal University, Hangzhou, China. hou.zheng@mail.mcgill.ca.
Ming LiuInstitute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. liuming@genetics.ac.cn.
Xu HuInstitute of Psychology, Chinese Academy of Sciences, Beijing, China. huxu@psych.ac.cn.
Tao WangInstitute of Psychology, Chinese Academy of Sciences, Beijing, China. wangt@psych.ac.cn.
Xingwei ZhangThe Affiliated Hospital, School of Medicine, Hangzhou Normal University, Hangzhou, China. xwzhang@medmail.com.cn.
Feng JinInstitute of Psychology, Chinese Academy of Sciences, Beijing, China. jinfeng@psych.ac.cn.
Li WangThe Affiliated Hospital, School of Medicine, Hangzhou Normal University, Hangzhou, China. liwang@hznu.edu.cn.
Affiliated Hospital of Hangzhou Normal University · CNInstitute of Physics · CNInstitute of Genetics and Developmental Biology · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKoumiss is a traditionally fermented mare's milk described with health-promoting potentials for decades. However, only a few studies focused on the probiotic strains isolated from koumiss. In this study, we collected koumiss samples from Inner Mongolian pasturing area of China and selected a promising strain of Lactobacillus helveticus, isolate NS8, based on the survival abilities in gastrointestinal tract (GIT) and adhesion to intestinal endothelial cells in vitro. As the ability to positively modulate host immune response is a feature of increasing importance in measuring the probiotic potential of a bacterial strain, our study mainly focus on the immunomodulatory properties of L. helveticus NS8 by using in vivo and ex vivo analyses.

resultsL. helveticus NS8 was identified by molecular-typing methods, both at genus and species levels. As a typical food niche-specific bacteria, NS8 showed a moderate survival ability in GIT environment in vitro. However, an excellent binding capacity to the human intestinal epithelial cells, along with significant autoaggregation and cell-surface hydrophobicity was observed. Additionally, the presence of S-layer protein was responsible for the cell surface properties of this strain. NS8 was found to be rather protective against TNBS (2,4,6-trinitrobenzene sulfonic acid)-induced murine colitis. In the meantime, co-culture with NS8 induced an increased level of secretion of anti-inflammatory cytokine IL-10 in peripheral blood mono-nuclear cells (PBMCs). Furthermore, NS8 was also able to diminish the proinflammatory effects of lipopolysaccharide (LPS) in mouse macrophage cell line RAW264.7 by inducing higher levels of IL-10. Specially, adding of the purified S-layer protein didn't influence the production of IL-10. The specific ligand-host receptor interactions on the NS8 specific immune responses need to be learned further.

conclusionIn summary, L. helveticus NS8 exhibited good probiotic and particularly immunomodulatory properties, with a potential for development of functional food commercially or therapeutic adjuvant for inflammatory diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsBacterial AdhesionCaco-2 CellsCells, CulturedColitisCultured Milk ProductsDisease Models, AnimalGastrointestinal TractHumansInterleukin-10Lactobacillus helveticusLeukocytes, MononuclearMembrane GlycoproteinsMiceMolecular TypingAnti-Inflammatory AgentsInterleukin-10Membrane GlycoproteinsS-layer proteinsTrinitrobenzenesulfonic Acid

Identifiers

PMID26428623
PMCPMC4591576
OpenAlexW2129763947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.